Head & Neck Cancer Education
Head and neck cancer treatment requires balancing immunotherapy, radiation, and surgical approaches while preserving function. Knowledge Med sessions help community providers navigate evolving treatment paradigms through interactive case simulations.
Non-promotional, independently reviewed sessions led by faculty from Johns Hopkins, Columbia, Mount Sinai, and other leading academic medical centers.
What Providers Navigate
Physicians managing head & neck squamous cell carcinoma face evolving treatment decisions that interactive, independently reviewed education can help address.
- Integrating PD-L1 CPS and HPV status into first-line treatment selection
- Managing recurrent or metastatic disease after prior platinum therapy
- Balancing treatment efficacy with function preservation
- Addressing supportive care needs including nutrition and speech/swallow
What Sessions Cover
Knowledge Med HNSCC sessions use interactive case simulations to address these topics and more.
- First-line immunotherapy in recurrent/metastatic HNSCC
- HPV-positive vs HPV-negative disease: treatment implications
- De-escalation strategies in favorable-risk disease
- Managing treatment-related toxicities and supportive care
Interactive HNSCC Sessions
Case Simulations
Work through realistic head & neck squamous cell carcinoma patient cases with expert faculty, making treatment decisions at each stage.
Live Polling
See how your clinical decisions compare to peers in real time — revealing practice patterns and knowledge gaps.
Personalized Report
Receive a session summary with your individual responses, peer benchmarks, and key HNSCC clinical takeaways.
More Solid Tumor Sessions
Knowledge Med offers interactive sessions across many indications — these are just some of the areas we cover.
Metastatic Colorectal Cancer
mCRC — Biomarker-driven first-line therapy selection in mCRC
HER2-Positive Breast Cancer
HER2+ — First-line treatment selection in HER2+ metastatic breast cancer
Metastatic Breast Cancer
mBC — First-line endocrine-based therapy selection in HR+/HER2- mBC
Triple-Negative Breast Cancer
TNBC — Immunotherapy in first-line metastatic TNBC: patient selection and regimens
Join a HNSCC Session
Third-party, non-promotional head & neck squamous cell carcinoma education led by faculty from leading academic medical centers. Case simulations. Live polling. Personalized insights.
Join a Session